- Share Prices
Immupharma PLC (IMM)
11.13p+3.06 (+38.03%)09 Sep 2025, 18:24
Immupharma PLC Market & Company News
01.09.2025 15:01 | IMM | Immupharma shares more than double on "groundbreaking" patent for P140 | Alliance |
01.09.2025 14:12 | IMM | Appointments of CSO and Head of R&D | RNS |
01.09.2025 13:20 | IMM | ImmuPharma Files New Patent Application for P140: | RNS |
20.08.2025 13:36 | IMM | Holding(s) in Company | RNS |
06.08.2025 22:08 | ASLI, PYC, MWE | EARNINGS AND TRADING: Tortilla Mexican Grill LFL sales growth slows | Alliance |
06.08.2025 11:01 | IMM, CTA, FARN | AIM WINNERS & LOSERS: CT Automotive to post half-year revenue decline | Alliance |
06.08.2025 07:00 | IMM | Interim Results | RNS |
12.06.2025 12:51 | IMM | Result of AGM | RNS |
05.06.2025 12:38 | TRU, TSCO, SWEF | UK shareholder meetings calendar - next 7 days | Alliance |
27.05.2025 15:13 | IMM | Holding(s) in Company | RNS |
20.05.2025 07:00 | IMM | Notice of AGM | RNS |
19.05.2025 10:37 | IMM | Immupharma annual loss narrows as focused on clinical assets | Alliance |
19.05.2025 07:00 | IMM | Final Results | RNS |
01.04.2025 07:00 | IMM | Warrant Extension, Debt Conversion & Equity Issue | RNS |
01.04.2025 07:00 | IMM | Extension of Warrants in Incanthera to 30 Sep 2025 | RNS |
14.03.2025 07:00 | IMM | IMM attending Bio-Europe Spring 17-19 March,Milan | Reach |
13.03.2025 16:27 | IMM | ImmuPharma celebrates "significant milestone" for P140 platform | Alliance |
13.03.2025 11:07 | CGL, IMM, ENET | AIM WINNERS & LOSERS: Hornby plots AIM exit; Ethernity deal progresses | Alliance |
13.03.2025 07:00 | IMM | ImmuPharma proves unique Mechanism of Action-P140 | RNS |
21.02.2025 11:36 | IMM | Holding(s) in Company | RNS |
13.02.2025 07:00 | IMM | £2.91m fundraising; related party transactions | RNS |
28.01.2025 14:28 | IMM | IN BRIEF: ImmuPharma notes share price surge after novel findings | Alliance |
28.01.2025 12:57 | IMM | Response to Share Price Movement | RNS |
09.01.2025 11:21 | IMM | IN BRIEF: ImmuPharma shares climb on breakthrough autoimmune findings | Alliance |
09.01.2025 09:53 | IPX, CRTA, IMM | AIM WINNERS & LOSERS: ImmuPharma jumps; Impax Asset hit by outflows | Alliance |
09.01.2025 07:00 | IMM | Breakthrough Findings into Autoimmune Diseases | RNS |
08.01.2025 07:00 | IMM | IMM at JP MORGAN CONFERENCE & BIOTECH SHOWCASE | Reach |
23.12.2024 07:00 | IMM | Change of Auditor | RNS |
04.12.2024 07:00 | IMM | Appointment of Company Secretary | RNS |
09.09.2024 16:46 | IMM | ImmuPharma narrows losses in first half as expenses fall | Alliance |
09.09.2024 12:45 | IMM | ImmuPharma obtains second warrant extension with Incanthera | Alliance |
09.09.2024 07:01 | IMM | Extension of Warrants in Incanthera to 31 Mar 2025 | RNS |
09.09.2024 07:00 | IMM | Half-year Report | RNS |
06.08.2024 13:41 | IMM | Holding(s) in Company | RNS |